Literature DB >> 21140111

Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis.

T T Htwe1, N Karim, J Wong, S Jahanfar, M A Mansur.   

Abstract

INTRODUCTION: Galectin-3 is a member of the beta-galactoside-binding protein family that plays an important role in cell-to-cell adhesion and in cell-to-matrix interaction. Cellular expression of galectin-3 is correlated with cancer aggressiveness and metastasis.
METHODS: We examined the differential expression of galectin-3 in a collection of 142 cases of thyroid lesions, including 108 cases of papillary thyroid carcinoma (PTC) and 34 cases of follicular carcinoma (FCA). An immunohistochemical method was applied and semiquantitative scoring was performed on the staining intensity of the positive tissue. Scoring was done on cells at the central portion of the tumour foci and on cells at the periphery that were adjacent to the neighbouring normal thyroid tissue matrix.
RESULTS: A significantly higher expression (p is 0.001) of galectin-3 was observed in the advancing peripheral thyroid cancer cells compared to the centrally located cells that were not in close contact with the neighbouring stromal tissue in cases with PTC compared to those with FCA.
CONCLUSION: This finding supported the role of galectin-3 in its cell-to-cell adhesion and cell-to-matrix interaction. Galectin-3 is a potential tumour marker for indicating local and distance metastasis, especially in cases with PTC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140111

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  9 in total

Review 1.  The Blood Biomarkers of Thyroid Cancer.

Authors:  Weiran Wang; Jingtao Chang; Baosong Jia; Jing Liu
Journal:  Cancer Manag Res       Date:  2020-07-06       Impact factor: 3.989

2.  Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms.

Authors:  Dalia Rifaat Al-Sharaky; Sheren Fouad Younes
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  Serum Galectin-3: diagnostic value for papillary thyroid carcinoma.

Authors:  Erdem Yılmaz; Tamer Karşıdağ; Cihad Tatar; Sefa Tüzün
Journal:  Ulus Cerrahi Derg       Date:  2015-04-09

4.  THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER.

Authors:  B I Aydoğan; C C Ersöz; S D Sak; S Güllü
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

5.  Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules.

Authors:  Kristine Ducena; Arturs Abols; Janis Vilmanis; Zenons Narbuts; Juris Tārs; Diana Andrējeva; Aija Linē; Valdis Pīrāgs
Journal:  Thyroid Res       Date:  2011-06-27

6.  Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis.

Authors:  Weiwei Tang; Congwei Huang; Chongyin Tang; Jin Xu; Hanjin Wang
Journal:  Onco Targets Ther       Date:  2016-01-22       Impact factor: 4.147

7.  Senescent thyroid tumor cells promote their migration by inducing the polarization of M2-like macrophages.

Authors:  C Zhang; X Gu; M Pan; Q Yuan; H Cheng
Journal:  Clin Transl Oncol       Date:  2021-01-03       Impact factor: 3.405

8.  Serum biomarkers of papillary thyroid cancer.

Authors:  Fawaz M Makki; S Mark Taylor; Ali Shahnavaz; Andrew Leslie; Jeffrey Gallant; Susan Douglas; Evelyn Teh; Jonathan Trites; Martin Bullock; Karen Inglis; Devanand M Pinto; Robert D Hart
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-02-07

9.  Interstitial fibrosis in papillary thyroid microcarcinoma and its association with biological behavior.

Authors:  Xun Liu; Shuai Zhang; Qinwei Gang; Shikai Shen; Jian Zhang; Yu Lun; Dongdong Xu; Zhiquan Duan; Shijie Xin
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.